Page 370 - CEO Orientation

Statement of Operations and Changes in Net Assets:

Statement of Operations and Changes in Net Assets - DRAFT (unaudited)
For the period ended November 30, 2017
(In thousands of dollars)

Budget Mar YTD
'18 YTD Budget YTD Actual Variance PYTD Actual Mar-17
$ $ $ $ $ $
Revenues
MOHLTC/TCLHIN/CCO 833,012 556,041 558,305 2,264 547,336 842,227
Patient revenues 59,002 41,032 44,199 3,167 40,913 60,379
Sales and other revenue 99,866 63,733 66,776 3,043 68,381 77,694
Grants and Donations for Research 88,335 58,890 58,890 - 57,444 71,659
Amortization of deferred contributions 18,689 12,487 12,809 322 12,816 19,302
1,098,904 732,183 740,979 8,796 726,890 1,071,261

Expenses
Salaries and employee benefits 721,141 480,699 478,785 1,914 469,706 711,129
Medical and surgical supplies 68,164 45,836 49,053 (3,217) 45,337 69,870
Drugs 55,590 37,978 39,093 (1,115) 37,594 57,071
Other supplies 204,668 134,870 140,891 (6,021) 135,888 184,021
Amortization of capital assets 46,278 30,971 31,262 (291) 30,417 46,606
1,095,840 730,354 739,084 (8,730) 718,942 1,068,697

Surplus (Deficit) for the period 3,064 1,829 1,895 66 7,948 2,564

Net assets - Beginning of period 322,703 322,703 322,703 - 320,139 320,139

Net assets - End of period 325,767 324,532 324,598 66 328,087 322,703

6